Evidence map›Paper›PMID 36388608›Full record

ArticleFrontiers in plant science2022

Targeted mutagenesis of the

Bicko Steve Juma, Asunta Mukami, Cecilia Mweu, Mathew Piero Ngugi, Wilton Mbinda

Open access · goldAbstract read
In one paragraph

Article in Frontiers in plant science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
9.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 47 citations in OpenAlex.

  1. Advances in CRISPR Plant Applications.International journal of molecular sciences · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Cyanogenesis, a Plant Defence Strategy against Herbivores.International journal of molecular sciences · 2023
    Review
  17. Review
  18. Article
  19. Review
  20. CRISPR-Cas9-mediated knockout ofFrontiers in plant science · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Bicko Steve JumaInstitute for Biotechnology Research, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.
Asunta MukamiDepartment of Biochemistry, Microbiology and Biotechnology, Kenyatta University, Nairobi, Kenya.
Cecilia MweuInstitute for Biotechnology Research, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.
Mathew Piero NgugiDepartment of Biochemistry, Microbiology and Biotechnology, Kenyatta University, Nairobi, Kenya.
Wilton MbindaDepartment of Department of Biochemistry and Biotechnology, Pwani University, Kilifi, Kenya.
Jomo Kenyatta University of Agriculture and Technology · KEKenyatta University · KEPwani University · KE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cassava is the world's most essential food root crop, generating calories to millions of Sub-Saharan African subsistence farmers. Cassava leaves and roots contain toxic quantities of the cyanogenic glycoside linamarin. Consumption of residual cyanogens results in cyanide poisoning due to conversion of the cyanogens to cyanide in the body. There is a need for acyanogenic cassava cultivars in order for it to become a consistently safe and acceptable food, and commercial crop. In recent years, the CRISPR/Cas system, has proven to be the most effective and successful genome editing tool for gene function studies and crop improvement. In this study, we performed targeted mutagenesis of the

Indexed as

cassavaCRISPR/Cas9cyanideMeCYP79D1targeted mutagenesis

Identifiers

PMID36388608
PMCPMC9644188
OpenAlexW4307258379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.